Cogent Biosciences (COGT) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free COGT Stock Alerts $7.53 +0.24 (+3.29%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Rises By 15.0%marketbeat.com - April 29 at 8:43 PMCogent Biosciences (NASDAQ:COGT) Shares Up 11.5%marketbeat.com - April 29 at 2:32 PMCogent Biosciences (NASDAQ:COGT) Trading Down 8.3%marketbeat.com - April 25 at 8:23 PMCogent Biosciences (NASDAQ:COGT) Shares Up 4%marketbeat.com - April 22 at 1:54 PMSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cogent Biosciences, Inc. (NASDAQ: COGT)prnewswire.com - April 18 at 9:00 AMCogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - April 14 at 4:23 AMCogent Biosciences (NASDAQ:COGT) Stock Price Down 7.3%marketbeat.com - April 10 at 12:57 PMCogent Biosciences (NASDAQ:COGT) Shares Up 6.3%marketbeat.com - April 9 at 2:46 PMCogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitorglobenewswire.com - April 9 at 9:00 AMCogent Biosciences (NASDAQ:COGT) Trading Down 8%marketbeat.com - April 2 at 5:45 PMCogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by SG Americas Securities LLCmarketbeat.com - March 28 at 4:48 AMCogent Biosciences (NASDAQ:COGT) Trading 10.4% Higher marketbeat.com - March 27 at 4:44 PMCogent Biosciences (NASDAQ:COGT) Trading Down 5.2%marketbeat.com - March 25 at 3:19 PMCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of "Moderate Buy" by Analystsmarketbeat.com - March 20 at 5:28 AMCogent Biosciences (NASDAQ:COGT) Shares Gap Down to $7.05marketbeat.com - March 18 at 11:24 AMCOGT Apr 2024 7.500 callfinance.yahoo.com - March 16 at 8:52 AMShort Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Expands By 45.4%marketbeat.com - March 15 at 10:36 PMCogent Biosciences (NASDAQ:COGT) Stock Price Up 2.4%marketbeat.com - March 14 at 11:57 AM5 Best Biotech Stocks To Buy Under $20insidermonkey.com - March 14 at 7:14 AMCogent Biosciences (NASDAQ:COGT) Trading Down 4%marketbeat.com - March 12 at 1:24 PMKynam Capital Management LP Has $21.55 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)marketbeat.com - March 4 at 3:46 PMCogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by Fmr LLCmarketbeat.com - March 2 at 5:13 AMLeerink Partnrs Equities Analysts Raise Earnings Estimates for Cogent Biosciences, Inc. (NASDAQ:COGT)marketbeat.com - February 29 at 8:53 AMCOGT Reports Full Year 2023 Financial Results and Business Highlightsfinance.yahoo.com - February 28 at 9:38 AMHC Wainwright Analysts Boost Earnings Estimates for Cogent Biosciences, Inc. (NASDAQ:COGT)marketbeat.com - February 28 at 8:39 AMBaird Downgrades Cogent Biosciences (COGT)msn.com - February 27 at 9:27 AMCogent Biosciences (NASDAQ:COGT) Issues Quarterly Earnings Results, Misses Estimates By $0.08 EPSmarketbeat.com - February 27 at 8:49 AMCogent Biosciences (NASDAQ:COGT) Price Target Raised to $13.00marketbeat.com - February 26 at 12:21 PMCogent Biosciences (NASDAQ:COGT) Shares Gap Down to $7.44marketbeat.com - February 26 at 11:53 AMCogent Biosciences GAAP EPS of -$0.63msn.com - February 26 at 9:50 AMCogent Biosciences' (COGT) Buy Rating Reiterated at Needham & Company LLCmarketbeat.com - February 26 at 8:25 AMCogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 26 at 8:00 AMCogent Biosciences (NASDAQ:COGT) Downgraded to "Neutral" at Robert W. Bairdmarketbeat.com - February 26 at 7:38 AMBuy Rating Affirmed for Cogent Biosciences as Bezuclastinib Showcases Strong Market Potentialmarkets.businessinsider.com - February 23 at 1:38 PMAnalysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)markets.businessinsider.com - February 23 at 1:38 PMWedbush Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $10.00marketbeat.com - February 23 at 8:31 AMCogent Biosciences stock jumps on Phase 2 data for bezuclastinibmsn.com - February 22 at 6:15 PMCogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosisglobenewswire.com - February 22 at 2:30 PMBuy Rating Affirmed on Cogent Biosciences Amid Positive Outlook for Bezuclastinib’s Efficacy and Safetymarkets.businessinsider.com - February 22 at 12:34 PMSteven Cohen's Point72 Asset Management Bolsters Position in Cogent Biosciencesfinance.yahoo.com - February 15 at 10:00 AMAnalysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Cogent Biosciences (COGT)markets.businessinsider.com - February 15 at 12:06 AMCogent Biosciences: Stock Soars On Cash Injection Ahead Of Major Data Catalystseekingalpha.com - February 14 at 3:30 PMCogent Biosciences (NASDAQ:COGT) Shares Gap Up to $5.46marketbeat.com - February 14 at 11:05 AMCogent Biosciences Announces Oversubscribed $225 Million Private Placementfinance.yahoo.com - February 14 at 9:04 AMCogent Biosciences Announces Oversubscribed $225 Million Private Placementglobenewswire.com - February 14 at 7:00 AMCogent Biosciences (NASDAQ:COGT) Rating Reiterated by Needham & Company LLCmarketbeat.com - February 12 at 8:19 AMCogent Biosciences (NASDAQ:COGT) Shares Down 6.4% marketbeat.com - February 9 at 4:30 PMCogent Biosciences (NASDAQ:COGT) Shares Gap Up to $5.95marketbeat.com - February 8 at 1:11 PMCogent Biosciences (NASDAQ:COGT) Trading Up 8.8%marketbeat.com - February 6 at 2:25 PMCogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meetingfinance.yahoo.com - February 5 at 2:30 PM Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. COGT Media Mentions By Week COGT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COGT News Sentiment▼1.260.42▲Average Medical News Sentiment COGT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COGT Articles This Week▼22▲COGT Articles Average Week Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SIGA Technologies News Dianthus Therapeutics News Pharming Group News Savara News Mineralys Therapeutics News Zymeworks News Wave Life Sciences News ORIC Pharmaceuticals News Nuvation Bio News Nurix Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COGT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
